This announcement is a separate document:
百奧賽圖-B:自願公告百奧賽圖與Radiance Biopharma達成雙特異性抗體偶聯協定
BIOCYTOGEN-B: VOLUNTARY ANNOUNCEMENTBIOCYTOGEN ENTERED INTO A BISPECIFIC ANTIBODYDRUG CONJUGATE AGREEMENT WITH RADIANCE BIOPHARMA
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.